E. Giziroglu et al. / Journal of Organometallic Chemistry 724 (2013) 251e254
253
Table 1
Fourier maps. Atomic coordinates, isotropic and anisotropic
displacement parameters of all the non-hydrogen atoms of the
compound were refined by means of a full matrix least-squares
procedure on F2. Drawings of the molecule were performed using
Ortep 3.
Selected bond lengths (Å) and angles (deg) with esd’s in parentheses, for complex 4.
Pd(1)eC(1)
Pd(1)eCl(1)
Pd(1)eC(29)
Pd(1)eC(30)
2.039(3)
2.383(7)
2.166(3)
2.120(4)
1.381(4)
95.12(7)
98.29(13)
103.7(2)
126.82(18)
167.22(14)
Pd(1)eC(31)
N(2)eC(4)
O(1)eC(6)
N(1)eC(1)
2.110(3)
1.389(3)
1.335(3)
1.331(3)
1.386(3)
129.23(19)
104.8(2)
132.4(2)
121.5(2)
97.55(12)
N(1)eC(2)
N(3)eN(4)
C(1)ePd(1)eCl(1)
C(1)ePd(1)eC(31)
N(1)eC(1)eN(2)
N(2)eC(1)ePd(1)
C(1)ePd(1)eC(29)
N(1)eC(1)ePd(1)
C(6)eC(5)eC(4)
O(1)eC(6)eC(5)
N(3)eC(4)eN(2)
C(29)ePd(1)eCl(1)
4.2. 5-Chloro-3-phenoxy-1,2-diphenylpyrazolium tetrafluoroborate 2
2,6-Dimethylphenol (1.86 g, 13.2 mmol) and triethylamine
(33 mL, 23.5 mmol) were added at 0 ꢀC to an acetonitrile (50 mL)
solution of 3,5-dichloro-1,2-diphenylpyrazolium tetrafluoroborate
1 (5.0 g, 13.2 mmol). After stirring for 6 h at 0 ꢀC, the reaction
mixture was concentrated to 1/2 of its original volume and then
diethyl ether (250 mL) was added to precipitate the product and
ammonium salts. After filtration, the solid residue was washed with
water (5 ꢂ 150 mL), and then with diethyl ether (3 ꢂ 40 mL). After
recrystallization from ethanol, 2 was obtained as a colorless solid
substituents on the pyrazolium and imidazolium rings and the
possibility of introducing a spacer between the pyrazolium and
imidazolium groups are under active investigation.
(3.55 g, 58%). m.p.: 138e141 ꢀC; 1H NMR (300 MHz, CDCl3):
(s, 6H), 5.94 (s, 1H), 7.16e7.17 (m, 3H), 7.47e7.51 (m, 6H), 7.69e7.72
(m, 4H) ppm; 13C NMR (75 MHz, CD3CN):
¼ 15.3, 92.5,127.8,128.0,
128.4, 129.4, 129.8, 130.2, 130.4, 132.1, 132.8, 133.3, 140.6, 150.1,
156.8 ppm; 11B NMR (96 MHz, CDCl3):
¼ ꢁ1.3 ppm.
d
¼ 2.34
4. Experimental
d
4.1. General
d
All manipulations and reactions were performed under a puri-
fied argon atmosphere using standard Schlenk techniques. Dry,
oxygen-free solvents were employed. Commercially available
reagents were used without further purification. 3,5-Dichloro-1,2-
diphenylpyrazolium tetrafluoroborate 1 was prepared according
to the reported procedures [9]. Melting points were measured with
an Electro thermal 9200 melting point apparatus and the values are
uncorrected. 1H, 13C and 11B NMR spectra were recorded on a Bruker
Avance 300 spectrometer. Chemical shifts are reported in ppm
downfield from Me4Si and were referenced to solvent peaks. X-ray
measurements were recorded on the Bruker X8-APEX [13] X-ray
diffraction instrument with Mo-radiation. All data frames were
4.3. 5-(1-Methyl-1H-imidazol-3-ium-3-yl)-3-phenoxy-1,
2-diphenylpyrazolium chloride tetrafluoroborate 3
1-Methylimidazole (0.45 g, 5.4 mmol) was added to a 5:1 CHCl3/
CH3CN solution (25 mL) of 2 (2.5 g, 5.4 mmol) at room temperature.
The solution was heated and stirred at 60 ꢀC for 6 h. The reaction
mixture was concentrated to 1/2 of its original volume and then
diethyl ether (250 mL) was added to precipitate the product. After
filtration, the solid residue was washed with diethyl ether, recrys-
tallized from a saturated acetonitrile solution at ꢁ30 ꢀC, and dried
under vacuum to give 3 as colorless crystals (2.43 g, 83%). m.p.:
collected at low temperatures (T ¼ 100 K) using an
u, 4-scan mode
(0.3ꢀ
u
-scan width, hemisphere of reflections) and integrated using
167 ꢀC (dec); 1H NMR (300 MHz, CDCl3):
d
¼ 2.38 (s, 6H), 3.90 (s,
a Bruker SAINTPLUS software package [14]. The intensity data were
corrected for lorentzian polarization. Absorption corrections were
performed using the SADABS program [15]. The SIR97 [16] software
was used for direct methods solution and phase determination, and
Bruker SHELXTL [17] for structure refinement and difference
3H), 6.22 (s, 1H), 7.08e7.10 (m, 3H), 7.30e7.49 (m, 8H), 7.88 (d,
JHH ¼ 6.6 Hz, 2H), 8.19 (d, JHH ¼ 7.34 Hz, 2H), 10.37 (s, 1H) ppm; 13
C
NMR (75 MHz, CD3CN):
d
¼ 16.2, 37.7, 92.3,124.2,125.7,128.9,129.6,
129.8, 130.4, 130.6, 130.9, 131.1, 131.2, 133.8, 133.9, 140.4, 151.0,
157.3 ppm; 11B NMR (96 MHz, CDCl3):
d
¼ ꢁ1.3 ppm.
Table 2
4.4. Allylchloro{1-[3-(2,6-dimethylphenoxy)-1,
2-diphenylpyrazoliumyl]-3-methyl-imidazol-2-ylidene}
palladium(II) tetrafluoroborate 4
Crystal data and structure refinement for complex 4.
Empirical formula
C30H30BClF4N4OPd
Formula weight
Temperature
Wavelength
691.24
100(2) K
0.71073 A
Monoclinic
C2/c
37.0409(7)
11.0088(2)
16.9809(3)
A mixture of [Pd(allyl)Cl]2 (0.23 g, 0.6 mmol), dicationic salt 3
(0.65 g, 1.2 mmol), and Et3N (0.22 mL, 1.6 mmol), was dissolved in
CH3CN (20 mL) and the solution was stirred at room temperature
for 2 h. After evaporation of the solvent the crude residue was
washed with water (2 ꢂ 20 mL). Then the organic layer was
extracted with CH2Cl2 (20 mL) and dried over anhydrous MgSO4.
After removal of the solvent under vacuum, 4 was obtained as
a white solid (0.29 g, 72%). Crystals [m.p.: 205 ꢀC (dec)] suitable for
X-ray crystallography were obtained by slow evaporation of
a chloroform solution of complex 4. 1H NMR (300 MHz, CDCl3):
ꢀ
Crystal system
Space group
ꢀ
a, A
ꢀ
b, A
ꢀ
c, A
a
, deg
, deg
90
b
105.7390(10)
90
6664.8(2)
8
1.378
0.687
30,293
5662
g
, deg
3
ꢀ
V, A
Z
d calc Mg mꢁ3
d
¼ 2.32 (d, JHH ¼ 13.6 Hz, 1H), 2.39 (s, 6H), 3.14 (d, JHH ¼ 13.6 Hz,
m
, mmꢁ1
1H), 3.56 (d, JHH ¼ 6.6 Hz, 1H), 3.71 (s, 3H), 4.22 (d, JHH ¼ 6.6 Hz, 1H),
5.03 (m, 1H), 5.98 (s, 1H), 7.11 (s, 2H), 7.27e7.34 (m, 5H), 7.43e7.60
(m, 4H), 7.74 (d, JHH ¼ 7.34 Hz, 2H), 8.02 (d, JHH ¼ 7.34 Hz, 2H) ppm;
Reflections collected
Nmeasd
[Rint
]
[0.0233]
13C NMR (75 MHz, CDCl3):
d
¼ 15.9, 38.5, 50.8, 72.4, 90.26, 114.9,
Final R indices [I > 2
R indices (all data)
GOF
s
(I)]
R1 ¼ 0.0319, wR2 ¼ 0.0830
R1 ¼ 0.0357, wR2 ¼ 0.0858
1.064
0.948, ꢁ0.655
122.9, 123.3, 127.6, 129.1, 129.3, 129.4, 129.6, 129.8, 130.5, 131.8,
132.2, 144.9, 150.3, 156.0, 184.0 (Ccarbene) ppm; 11B NMR (96 MHz,
ꢀꢁ3
Largest diff. peak and hole [e A
]
CDCl3):
d
¼ ꢁ1.2 ppm.